nivolumab,Vidutolimod
bms,checkmate pharmaceuticals
['nivo']
neoadjuvant type a cpg vidu+nivo in high-risk resectable #melanoma. clear innate and pdc activation in responders. gut microbiota supporting tlr9 distinct from a-pd-1. more data to be presented in the oral session 121. #cpgrocks 